NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global surgical robots…
Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and moreGLP-1 drugs expected to generate multi-hundreds of billions…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference…
SAN DIEGO, Nov. 25, 2024 /PRNewswire/ -- Cortechs.ai, a leading provider of AI-powered imaging solutions, is excited to announce that…
New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysisAccelerating global expansion with cutting-edge…
The designation is a result of UNEEG's strong focus on developing novel disease management support tools with transformational and first-to-market…
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / November 25, 2024…
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis data in potentially pivotal GBM…
LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses…